![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
Pfizer Inc. and BioNTech SE announced that they have submitted an amended protocol to the U.S. Food and Drug Administration to expand the enrollment...
Clinical Trials
Takeda Announces Results from Phase 3 Clinical Trial Evaluating NINLARO in Newly Diagnosed Multiple Myeloma
Takeda Pharmaceutical Company Limited announced results from the Phase 3 TOURMALINE-MM2 trial evaluating the addition of NINLARO™ (ixazomib) to lenalidomide and dexamethasone versus lenalidomide...
Clinical Trials
Phesi data show clinical trial suspensions continue to rise as COVID-19 impact on development persists
Analysis from Phesi shows the impact of COVID-19 on clinical development is continuing to mount, with many clinical trial sites unable to bounce back...
Clinical Trials
Merck announces positive results phase 3 trials of gefapixant 45 mg twice daily in patients with refractory or unexplained chronic cough
Merck, known as MSD outside the United States and Canada, has announced the results from two pivotal phase 3 trials (COUGH-1 and COUGH-2) evaluating...
Clinical Trials
Sharp launches Clinventory Inventory Management System (IMS) for clinical trials
Sharp - part of UDG Healthcare plc, a global leader in contract packaging clinical supply services, has launched a new Inventory Management System (IMS)...
Clinical Trials
Sinovac Biotech’s COVID-19 vaccine enters phase 3 trial globally
A COVID-19 vaccine candidate developed by Beijing-based Sinovac Life Sciences Corp has obtained preliminary approval in Bangladesh for entering phase III clinical trials, the...
Clinical Trials
Bharat Biotech gets approval to conduct phase 2 trials of COVID-19 vaccine Covaxin
Hyderabad-based Bharat Biotech has received approval to conduct phase II trials of its COVID-19 vaccine Covaxin from September 7.
The Directorate General of Health Service...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read